The frequency of type 2 CD8+ T cells is increased in peripheral blood from patients with psoriasis vulgaris

Journal of Clinical Immunology

Volumn 23, Issue 4, 2003, Pages 269-278

  Inaoki, Makoto ^a   Sato, Shinichi ^a   Shirasaki, Fumiaki ^a   Mukaida, Naofumi ^b   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

CCR4; Interleukin 4; Psoriasis vulgaris; Tc2 cells

Indexed keywords

CD8 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CYTOKINE RELEASE; DISEASE SEVERITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPHOCYTIC INFILTRATION; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, CHEMOKINE; SKIN;

EID: 0037825761     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024584732614     Document Type: Article

References (43)

1. Nickoloff BJ: The immunologic and genetic basis of psoriasis. Arch Dermatol 135:1104-1110, 1999
2. + T cells induces psoriasis. Am J Pathol 155:145-158, 1999
3. + immunocompetent cells and endothelial cells is a major feature of psoriatic lesions. Arch Derm Res 286:87-96, 1994
4. Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, Kapsenberg ML: Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+) in both normal and diseased human skin. Arch Derm Res 281:24-30, 1989
5. Jones LJ, Berth-Jones J, Fletcher A, Hutchinson PE: Assessment of epidermal dendritic cell markers and T-lymphocytes in psoriasis. J Pathol 174:77-82, 1994
6. Paukkonen K, Naukkarinen A, Horsmanheimo M: The development of manifest psoriatic lesions is linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis. Arch Dermatol Res 284:375-379, 1992
7. Baker BS, Swain AF, Griffiths CEM, Leonard JN, Fry L, Valdimarsson H: Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin Exp Immunol 61:526-534, 1985
8. Baker BS, Griffiths CEM, Lambert S, Powles AV, Leonard JN, Valdimarsson H, Fry L: The effects of cyclosporine A on T lymphocyte and dendritic cell subpopulations in psoriasis. Transplant Proc 20:72-77, 1988
9. 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1:442-447, 1995
10. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282, 1991
11. Mosmann TR, Sad S: The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
12. Sad S, Marcotte R, Mosmann TR: Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2:271-279, 1995
13. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG: The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-g, interleukin-2, and tumor necrosis factor-a, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113:752-759, 1999
14. c2 profiles in periphral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. J Allergy Clin Immunol 107:337-344, 2001
15. Sallusto F, Lanzavecchia A, Mackay CR: Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568-574, 1998
16. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134, 1998
17. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nikoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701-705, 1993
18. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Buschenfelde K-H, Fleischer B: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145-149, 1994
19. + T cells in chronic plaque psoriasis are Tc1 cells producing heterogeneous levels of interferon-gamma. Exp Dermatol 10:168-174, 2001
20. + subsets. J Invest Dermatol 111:1072-1078, 1998
21. Friedrich M, Krammig S, Henze M, Docke WD, Sterry W, Asadullah K: Flow cytometric characterization of lesional T cells in psoriasis: Intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype. Arch Dermatol Res 292:519-521, 2000
22. Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG: Potential role of the chemokine receptors CXCR3, CCR4, and the integrin αEβ7 in the pathogenesis of psoriasis vulgaris. Lab Invest 81:335-347, 2001
23. + T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 117:188-196, 2001
24. Teraki Y, Hotta T, Shiohara T: Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type-1 cytokine-producing cells in atopic dermatitis. Br J Dermatol 143:373-378, 2000
25. Barna M, Snijdewint FGM, van der Heijden FL, Bos JD, Kapsenberg ML: Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venereol 186:9-11, 1994
26. Fredriksson T, Pettersson U: Severe psoriasis - Oral therapy with a new retinoid. Dermatologica 157:238-244, 1978
27. Rajka G, Langeland T: Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 144:13-14, 1989
28. Jung T, Schauer U, Heusser C, Neumann C, Rieger C: Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197-207, 1993
29. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC: Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408-1419, 1995
30. h2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81-88, 1999
31. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang MLK, Tedder TF: CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 5:551-562, 1996
32. + T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 107:353-358, 2001
33. Sato A, Tsuji K, Yamamura M, Morita Y, Kanzaki H, Tada J, Makino H, Arata J: Increased type 2 cytokine expression by both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis. J Invest Dermatol 111:1079-1084, 1998
34. Maggi E, Manetti R, Annunziato F, Cosmi L, Giudizi MG, Biagiotti R, Galli G, Zuccati G, Romagnani S: Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus-infected individuals. Blood 89:3672-3681, 1997
35. Stanciu LA, Shute J, Promwong C, Holgate ST, Djukanovic R: Increased levels of IL-4 in CD8+ T cells in atopic asthma. J Allergy Clin Immunol 100:373-378, 1997
36. Ochi H, Wu XM, Osoegawa M, Horiuchi I, Minohara M, Murai H, Ohyagi Y, Furuya H, Kira J: Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. J Neuroimmunol 119:297-305, 2001
37. + regulatory cells. J Immunol 167:107-113, 2001
38. Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM: Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distincT cell surface and funtional phenotypes. Blood 95:231-240, 2000
39. + T cells. J Exp Med 184:19-29, 1996
40. Huang BB, Bonish BK, Chaturvedi V, Qin J-Z, Nickoloff BJ: Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-g and Th-2 cytokines IL-4 and IL-13: Relevance to psoriasis. J Invest Dermatol 116:305-312, 2001
41. Dobrzanski MJ, Reome JB, Dutton RW: Role of effector cell-derived IL-4, IL-5, and perforin in early stages of type 2 CD8 effector cell-mediated tumor rejection. J Immunol 167:424-434, 2001
42. + T cells limits their cytokine synthesis and proliferation. J Exp Med 184:1543-1547, 1996
43. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 180:489-495, 1994